Alcon shares fall as lens competition and tariff refund cloud earnings growth
Alcon's stock declined after the eye-care company narrowed its annual earnings outlook and reported weaker implantable-product sales, particularly due to US competitive pressure in intraocular lenses. Despite stronger quarterly earnings and cash generation, the durability of growth is being questioned, especially as a significant tariff refund artificially boosted operating income. Analysts expressed uncertainty regarding the company's growth trajectory without this one-off benefit.
Cooper Companies director Kurzius buys $549,320 in stock
Lawrence Erik Kurzius, a director at The Cooper Companies, Inc. (NYSE:COO), recently acquired 10,000 shares of the company's common stock for $549,320. This purchase was made at a significant discount to the current stock price and aligns with an InvestingPro Tip indicating aggressive share buybacks by management. Despite recent challenges including a revenue miss and lowered guidance, analysts hold mixed ratings, with some maintaining Buy ratings while others have downgraded or reiterated Neutral positions.
Form 4 Cooper Companies Inc: Lawrence Erik Kurzius (Director) For: 16 September
This article reports on a Form 4 filing for Cooper Companies Inc, specifically detailing a transaction by Director Lawrence Erik Kurzius. The filing is dated September 16th. The content is a brief announcement without further details on the nature of the transaction.
MSCI: IREN, JBS, COOPER COMPANIES TO BE ADDED TO MSCI GLOBAL SMALL CAP INDEXES
MSCI announced that IREN, JBS, and Cooper Companies will be added to the MSCI Global Small Cap Indexes. This inclusion signifies increased visibility and potential investment for these companies within the global market.
Alcon shares fall as US implant lens competition and a $58 million tariff refund cloud its third quarter
Alcon's shares fell after its Q3 results revealed a decline in implantable lens sales due to US competition and operating profit boosted by a one-off $58 million tariff refund. While overall sales rose 5% to $2.72 billion, intraocular lens sales dropped, causing analysts to note that without the refund, operating profit would have missed expectations. The company narrowed its 2026 sales and core EPS guidance amidst uncertainty about its growth trajectory.
Repay Holdings Q3 2026 Earnings Call Transcript
Repay Holdings Corporation reported a 97% year-over-year increase in third-quarter revenue to $153.4 million, driven by political media contributions and strong Business Payments growth. The integration of Kubra is progressing, exceeding synergy targets, and the company is leveraging AI for operational efficiencies and product enhancements. Despite underperformance in Consumer Payments, management is implementing changes for future growth and reiterated full-year 2026 revenue guidance of $490 million to $500 million and adjusted EBITDA of $168.5 million to $176 million.
Should Raised Revenue Guidance Require Action From Bausch + Lomb Stock Investors?
Bausch + Lomb (NYSE:BLCO) reported Q3 2026 revenue of US$1.375 billion and a net income of US$32 million, moving from a loss a year earlier. The company also modestly raised its full-year 2026 revenue guidance to a range of US$5.45 billion to US$5.55 billion. This improved financial performance, particularly the shift to profitability, reinforces the investment thesis for Bausch + Lomb, though investors will continue to monitor execution on efficiency programs and consistent profitability.
The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of The Cooper Companies, Inc. (NASDAQ: COO) due to allegations of materially misleading business information. This investigation follows a 14.6% stock drop on September 10, 2026, after a disappointing earnings report and the decision not to sell Cooper Surgical. Investors who suffered losses are encouraged to contact the firm for potential compensation through a class action.
Timberland Bancorp (NASDAQ:TSBK) COO Sells $95,520.00 in Stock
Timberland Bancorp's COO, Jonathan Fischer, sold 2,000 shares of TSBK stock for $95,520, reducing his direct ownership by nearly 20%. This transaction occurred as the company reported strong quarterly earnings of $1.04 EPS on $22.78 million in revenue and increased its quarterly dividend. Analysts maintain a "Strong Buy" rating for Timberland Bancorp.
CooperCompanies sets Q4 and full-year 2026 earnings release for Dec 3 with a follow-up call.
CooperCompanies announced it will release its financial results for the fourth quarter and full year of 2026 on December 3, 2026, at 4:15 PM ET, with a follow-up conference call at 5:00 PM ET. The global medical device firm, trading under COO, had a recent stock price of USD 63.57, down 1.32% in the past day, with a market cap of $12.25 billion. Investors can access the call via phone or webcast.
Alcon Inc. (ALC) stock price, news, quote and history
Alcon Inc. (ALC) is currently trading at $77.74, up 7.42%, with a market capitalization of $37.58 billion. The company, headquartered in Geneva, Switzerland, specializes in eye care products, operating through Surgical and Vision Care segments. Alcon has a 1-year target estimate of $81.98 and a recent "Buy" rating from Needham with a price target of $98.
Bronstein, Gewirtz & Grossman, LLC Is Investigating The Cooper Co
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against The Cooper Companies, Inc. (NASDAQ: COO) following a significant drop in its stock price. This investigation comes after Cooper Companies announced its Q3 2026 results, which included flat year-over-year revenue, channel inventory reductions impacting results, and a lowered full-year guidance for both revenue and EPS. Shareholders who purchased Cooper Companies securities are encouraged to connect with the firm.
Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO
The Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) following a significant stock drop. This decline occurred on September 10, 2026, after a "Motley Fool" article highlighted weak guidance and the company's decision not to sell CooperSurgical, causing a 14.6% fall in stock value. Investors who purchased Cooper Companies securities are encouraged to inquire about joining a prospective class action to seek compensation.
Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO
Rosen Law Firm is investigating potential securities claims on behalf of investors in The Cooper Companies, Inc. (NASDAQ: COO). This investigation stems from allegations that Cooper Companies may have issued materially misleading business information, which led to a significant stock drop on September 10, 2026, after a disappointing earnings report and weak guidance. The firm encourages affected investors to inquire about joining a prospective class action.
The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) on behalf of shareholders who may have suffered losses due to allegedly misleading business information. This investigation follows a 14.6% stock drop on September 10, 2026, after a disappointing earnings report and the decision not to sell Cooper Surgical. Investors who purchased Cooper Companies securities are encouraged to contact the firm about joining a prospective class action for compensation.
Leadership watch: LENZ, CooperCompanies CEOs step down, among exec changes
This article details significant leadership changes in the eyecare industry, including the stepping down of CEOs at LENZ Therapeutics and CooperCompanies. LENZ Therapeutics is undergoing a strategic reorganization, cutting 75% of its workforce, while CooperCompanies' new Executive Chair, Walter Rosebrough, aims to address recent performance issues. Other executive appointments are also highlighted across Carl Zeiss Meditec AG, Tarsus Pharmaceuticals, RxSight, Zenni Optical, Balance Ophthalmics, and Ocuco.
CooperCompanies ousts CEO, taps new board chair amid investor pressure
CooperCompanies has replaced its CEO, appointed an executive chairman, and announced further board changes following pressure from activist investor JANA Partners. Albert White III is stepping down as CEO, and Walter M. Rosebrough Jr. has been elected executive chair, overseeing day-to-day operations during the search for a permanent CEO. These changes are in response to JANA's criticism of the company's underperformance, problematic financial forecasting, and poor capital allocation.
The Cooper Companies, Inc. Investor News: If You Have
The Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) following a 14.6% stock drop on September 10, 2026. This decline occurred after a disappointing earnings report, weak guidance, and the decision not to sell Cooper Surgical, as reported by The Motley Fool. The firm encourages investors who suffered losses to contact them for information on a prospective class action lawsuit.
The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) after its stock fell 14.6% on September 10, 2026, following a disappointing earnings report and weak guidance. Shareholders who suffered losses are encouraged to contact the firm to learn about joining a prospective class action for compensation. The investigation stems from allegations that Cooper Companies may have issued materially misleading business information to investors.
IQVIA Holdings Inc. (IQV) stock price, news, quote and history
IQVIA Holdings Inc. (IQV) is currently trading at $262.69, up 1.64%, with a market capitalization of $43.291 billion. The company, a provider of clinical research and healthcare intelligence services, has shown a year-to-date return of 16.52%. Analysts have an average 1-year target price of $311.89 for IQV, with recent ratings maintaining a "Buy" recommendation.
Lost Money on The Cooper Companies, Inc. Stock? Glancy
Glancy Prongay Wolke & Rotter LLP is investigating The Cooper Companies, Inc. (NASDAQ: COO) for possible securities fraud following a 14.67% stock price drop. The investigation stems from the September 9, 2026, announcement of flat Q3 2026 revenue and reduced full-year guidance due to U.S. channel inventory reductions. Investors who lost money are encouraged to contact Glancy to learn about potentially recovering their losses.
Lost Money on The Cooper Companies, Inc. Shares? The Law Offices of Frank R. Cruz Continues Investigating Potential Securities Fraud After 14.67% Stock Decline
The Law Offices of Frank R. Cruz is investigating potential securities fraud claims against The Cooper Companies, Inc. (NASDAQ: COO) after a 14.67% stock decline. This follows the company's September 9, 2026 announcement of flat revenue and reduced full-year guidance due to U.S. channel inventory reductions. Investors who suffered losses are encouraged to contact the firm to learn about potential claims to recover their losses.
Lost Money on The Cooper Companies, Inc. Shares? The Law Offices of Frank R. Cruz Continues Investigating Potential Securities Fraud After 14.67% Stock Decline
The Law Offices of Frank R. Cruz is investigating potential securities fraud claims against The Cooper Companies, Inc. after its shares declined 14.67% following a September 9, 2026, disclosure. The company announced flat revenue and lowered its full-year guidance due to U.S. channel inventory reductions, causing a significant stock drop. Investors who suffered losses are encouraged to contact the firm to learn about their options for recovering losses.
Lost Money on The Cooper Companies, Inc. Shares? The Law
The Law Offices of Frank R. Cruz is investigating potential securities fraud claims against The Cooper Companies, Inc. (NASDAQ: COO) after its shares declined by 14.67% following the September 9, 2026, announcement of flat third-quarter revenue and reduced full-year guidance due to U.S. channel inventory reductions. Investors who suffered losses on their CooperCompanies securities are encouraged to contact the firm to learn about potential claims to recover their losses. The investigation aims to determine if the company violated federal securities laws by providing incomplete or inaccurate information to investors prior to the disclosure.
Cooper Cos. Inc.. CEO exits, board refreshed amid activist shareholder's campaign
Cooper Cos. Inc. CEO Al White has been forced out following a campaign by activist shareholder Jana Partners. He will remain with the company as an adviser until April 1. This change comes alongside a refreshed board as a result of the activist pressure.
32.4M votes back a merger that would make Varex Imaging (VREX) a wholly owned subsidiary.
Varex Imaging Corporation (VREX) stockholders have approved the merger agreement with Teledyne Technologies Incorporated, with 32,426,328 votes in favor. This approval means Varex will become a wholly owned subsidiary of Teledyne, pending regulatory clearances, waiting-period expirations, and other contractual conditions. The compensation proposal for named executive officers was also approved.
The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) after its stock fell 14.6% on September 10, 2026. This decline followed a disappointing earnings report, weak guidance, and the company's decision not to sell Cooper Surgical. Shareholders who suffered losses are encouraged to contact the firm regarding a prospective class action.
Cooper Companies CEO steps down after activist investor pressure
Albert White has stepped down as president and CEO of Cooper Companies, with Walter Rosebrough Jr. taking over day-to-day operations and becoming executive chair. This move follows pressure from activist investor Jana Partners, who called for leadership changes and the potential sale of company assets after Cooper reduced its full-year forecasts. Cooper is now searching for a permanent CEO and is also changing its board of directors.
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Repligen (RGEN) and Cooper Co (COO)
Analysts have provided varied ratings for three healthcare companies. RBC Capital reiterated a Buy rating for IQVIA Holdings with a price target of $319.00, while also maintaining a Buy rating for Repligen with a $200.00 price target. Piper Sandler, however, maintained a Hold rating on Cooper Co with a price target of $59.00.
CooperCompanies: Leadership Change Amid Weak Performance Raises More Questions
CooperCompanies announced that CEO Albert White is stepping down, with independent director Walter Rosebrough taking over as interim CEO. The change comes amidst weak performance for the company, raising further questions from analysts. Shares traded sideways after the announcement.
The Cooper Companies, Inc. (COO) Stock Forecasts
An analyst report from Morningstar on October 27, 2026, examines The Cooper Companies, Inc. (COO), one of the largest eyecare companies in the US. The report, titled "CooperCompanies: Leadership Change Amid Weak Performance Raises More Questions," discusses the company's two segments: CooperVision and CooperSurgical. The full report offers in-depth analysis on the company's performance and recent leadership changes.
The Cooper Companies, Inc. (COO) stock price, news, quote and history
The Cooper Companies, Inc. (COO) stock currently trades at $59.41, experiencing a slight decline of 0.78% at close. The article provides detailed financial data, including market capitalization of $11.297 billion, a P/E ratio of 20.42, and an average analyst price target of $65.80. Cooper Companies operates in medical instruments and supplies, with segments in contact lenses (CooperVision) and women's health care (CooperSurgical).
Cooper Companies CEO White steps down
Cooper Companies announced that CEO Al White has stepped down, effective immediately, with board member Walt Rosebrough elected executive chair to oversee operations during the search for a new CEO. The leadership change comes after recent performance did not meet expectations, with activist investors involved, and is seen as a potential step toward improving shareholder value. White will remain as a strategic adviser through April 2027, and the company also announced new board appointments and reaffirmed its fiscal 2026 forecast.
Cooper Companies CEO White steps down
Cooper Companies announced that CEO Al White has stepped down immediately, with board member Walt Rosebrough taking over as executive chair while the company searches for a new CEO. The leadership change comes amid dissatisfaction with recent performance and the involvement of activist investors, although the company reaffirmed its fiscal 2026 forecast.
Cooper Companies CEO White steps down; board member Rosebrough named executive chair
Cooper Companies announced that CEO Al White has stepped down immediately, with board member Walt Rosebrough elected executive chair to oversee operations during the search for a new CEO. The leadership change comes amid pressure from activist investors and recent performance that did not meet expectations. The company also reaffirmed its fiscal 2026 forecast.
Cooper Companies’ Albert White exits CEO role; Walter Rosebrough named interim executive chair
Albert G. White III has resigned as president and CEO of Cooper Companies and left its board, with director Walter M. Rosebrough, Jr. stepping in as interim executive chair. This change was effective October 27, 2026, and a committee has been formed to find a permanent CEO. Additionally, several directors will not stand for re-election at the 2027 Annual Meeting.
Cooper Companies CEO White steps down; board member Rosebrough named executive chair
Cooper Companies announced that CEO Al White has stepped down, with board member Walt Rosebrough appointed as executive chair during the search for a new CEO. This leadership change comes amid activist investor involvement and concerns over recent performance and the failure to sell the women's health business. The company also reaffirmed its fiscal 2026 forecast.
Cooper Companies CEO White steps down; board member Rosebrough named executive chair
Cooper Companies announced that CEO Al White has stepped down, effective immediately, with board member Walt Rosebrough elected as executive chair while the company searches for a new CEO. This leadership change comes amid recent performance not meeting expectations and follows involvement from activist investors. The company also reaffirmed its fiscal 2026 forecast.
Form 8K Cooper Companies Inc For: 27 October By Investing.com
This article announces that Cooper Companies Inc. filed a Form 8K on October 27, 2026. The Form 8K filing is a report that U.S. public companies must file with the Securities and Exchange Commission (SEC) to announce significant events that shareholders should know about. The article provides the title of the filing and mentions the company's stock symbol, COO, along with its current performance.
CooperCompanies Announces Leadership Transition and Board Refreshment
CooperCompanies announced a leadership transition, with independent director Walt Rosebrough elected Executive Chair, and Albert White III stepping down as CEO. The company has initiated a search for a permanent CEO and is refreshing its Board of Directors with the planned addition of Shlomi Nachman and the departure of three current members. CooperCompanies reaffirmed its full-year fiscal 2026 guidance, emphasizing a commitment to strengthening operational execution and enhancing shareholder value.
Form 8K Cooper Companies Inc For: 27 October By Investing.com
This article announces that Cooper Companies Inc. filed a Form 8K on October 27, 2026. The filing is a routine disclosure of significant events that shareholders should know about. The article includes the company's stock symbol (COO) and its current performance (-2.06%).
CooperCompanies CEO steps down as board names executive chair
CooperCompanies announced that Albert White III has stepped down as President and CEO, effective immediately. Walter Rosebrough Jr., an independent director, has been named Executive Chair to oversee operations until a permanent CEO is found, with White remaining as an advisor. The company also announced board changes, including the addition of Shlomi Nachman and the departure of three current members, while reaffirming its fiscal year 2026 guidance.
CEO departs as Cooper Companies (COO) puts an independent director in charge.
The Cooper Companies, Inc. (COO) announced that CEO Albert G. White III has resigned, effective October 27, 2026, though he will remain as a strategic advisor until April 1, 2027, to aid in the transition. Independent director Walter M. Rosebrough, Jr. has been appointed interim Executive Chair and will oversee daily operations while a CEO Search Committee looks for a permanent replacement. The company also reaffirmed its fiscal year 2026 guidance amidst these leadership changes and planned board refreshment.
Form 8K Cooper Companies Inc For: 27 October By Investing.com
This article announces that Cooper Companies Inc. filed a Form 8K for October 27. The Form 8K is a crucial SEC filing used by public companies to announce major events that shareholders should know about. The brief piece indicates that investors can access this information for Cooper Companies Inc.
Cooper Companies CEO White steps down; board member Rosebrough named executive chair
Cooper Companies announced that CEO Al White has stepped down immediately, with board member Walt Rosebrough appointed as executive chair during the search for a new CEO. Rosebrough noted that recent performance has not met expectations, prompting the board's decisive action. The company reaffirmed its fiscal 2026 forecast.
Cooper Companies CEO White steps down
Cooper Companies announced that CEO Al White has stepped down, effective immediately, with board member Walt Rosebrough taking over as executive chair while the company searches for a new CEO. The leadership change comes amid activist investor involvement and concerns about recent performance not meeting expectations, prompting decisive action from the board. J.P. Morgan analyst Robbie Marcus noted that this overhaul could be an initial step towards improving shareholder value.
Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO
The Rosen Law Firm is investigating potential securities claims on behalf of investors in The Cooper Companies, Inc. (NASDAQ: COO). This investigation follows a 14.6% stock drop on September 10, 2026, after a disappointing earnings report, weak guidance, and a decision not to sell CooperSurgical. Investors who purchased Cooper Companies securities may be entitled to compensation through a class action lawsuit.
Stryker Corp under investigation for possible securities fraud
Stryker Corporation is under investigation by the Law Offices of Howard G. Smith for potential securities fraud following significant share price declines. The inquiry stems from the company's disclosure of supply chain disruptions leading to backorders and lost sales in Q2 2026, which continued into Q3. Investors who experienced losses are encouraged to contact the law firm.
The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) following a 14.6% stock drop on September 10, 2026. This decline occurred after a disappointing earnings report, weak guidance, and a decision not to sell Cooper Surgical. Shareholders who suffered losses are encouraged to contact The Rosen Law Firm for information on joining a prospective class action to recover investor losses.
Bausch + Lomb (BLCO) Signals Higher EBITDA Guidance, Is The Stock Still Undervalued?
Bausch + Lomb (BLCO) is in focus after a leadership change and plans to raise its full-year 2026 adjusted EBITDA outlook due to strong third-quarter performance. Despite being framed as 10% undervalued at $17.43 against a fair value of $19.39, the company faces risks if its $171 million loss continues or surgical demand is affected by refractive procedure softness. The article suggests considering Bausch + Lomb's 3 key rewards and 1 important warning sign for further investment decisions.
